Thromboembolic complications have been frequently reported in patients with long-lasting nephrotic syndrome (NS).[@b1] Although thrombotic complications in the venous system are common in patients with NS, arterial thromboses associated with NS are much less common.[@b1] However, coronary thromboses are extremely rarely observed.[@b1],[@b2] So, NS is a rare cause of acute coronary syndrome (ACS). As such, the incidence, pathogenesis, and treatment of these patients have yet to be clearly defined. In the current literature, publications contain less than 15 patients, most of whom are young children.[@b3]

Serious clotting factor disturbances can be observed, such as changes in platelet hyperfunction, increased plasma fibrinogen, abnormalities of the fibrinolytic system, and acquired deficiencies of coagulation inhibitors.[@b2] However, increased platelet aggregation and antithrombin III (AT III) deficiency are the most important factors in this hypercoagulable state in the NS.[@b4] A hypothesis for hypercoagulable state in NS suggests a clinical correlation between thromboembolism and the underlying renal disease (especially minimal change glomerulopathy).[@b1],[@b2],[@b5],[@b6] Patients with chronic excess proteinuria and long-term exposure to abnormalities of hemostasis and lipid profiles appear to have a high risk of developing cardiovascular disease.[@b4]

In our study, we evaluated the characteristics of eight patients admitted to our hospital with a diagnosis of acute myocardial infarction (AMI) by ECG, clinical presentation and myocardial enzyme. They were all diagnosed NS before AMI. To our knowledge, this is the first study of multiple cases of NS associated with AMI.

In this case study, the cases presented here were retrospectively collected from a database of Jinling Hospital in which who had AMI. From 1800 patients who had been admitted to our Department for AMI, we found eight cases of combined NS. These patients were enrolled in the study from 2008 through 2016. All patients were diagnosed with NS and meanwhile AMI based on symptoms, electrocardiogram and myocardial enzyme. Follow-up at one year was achieved in 62.5% patients.

Two of the patients were female (25%) and six of the patients were male. The age range was between 29 and 72 years with a mean age of 55 years (54.5 years for men, 56.5 years for women). Seven patients (87.5%) are taking oral hormone therapy for a long time. Patients with specific pathologic diagnosis were membranous nephropathy (MN) while three of them have no data. The most infarcted area is inferior wall (62.5%). Three patients died during hospitalization. Severe hypoalbuminemia and proteinuria can be observed in most of the patients ([Table 1](#jgc-14-07-481-t01){ref-type="table"}).

###### Baseline clinical characteristics of patients.

  Patients                                                                      1                             2                                     3                            4                             5                              6               7               8
  ----------------------------------------------------------------- ------------------------- --------------------------------- ----------------------------------------- --------------- -------------------------------------------- --------------- --------------- ---------------
  Age, yrs                                                                     29                            54                                    65                           59                             58                            72              62              41
  Gender                                                                      Male                          Male                                  Male                         Male                           Male                         Female           Male           Female
  Hypertension                                                                 No                            No                                    Yes                          Yes                            No                            Yes             Yes             No
  Diabetes                                                                     No                            No                                    No                           Yes                            No                            No              No              No
  Dyslipidemia                                                                 Yes                           No                                    No                           No                             No                            No              No              No
  Smoking                                                                      No                            Yes                                   No                           Yes                            No                            No              No              No
  Previous heart disease                                                       No                            No                                    No                           No                             No                            No              No              No
  Troponin I, ng/L                                                             ND                           42.03                                 1.71                         117.9                           NA                            NA              NA              50
  Oral glucocorticoids treatment                                               Yes                           Yes                                   Yes                          Yes                           Yes                            Yes             No              Yes
  Pathological diagnosis                                                       ND                            MN                                    MN                           ND                             MN                            MN              MN              ND
  Albumin, g/L                                                                 ND                           25.8                                  30.8                         18.1                           19.8                          33.3            25.9            16.1
  Proteinuria                                                                  No                            Yes                                   Yes                          Yes                            NA                            Yes             Yes             Yes
  The interval between the diagnosis and the onset of the disease           21 years                      5 months                               3 years                      1 year                           ND                          6 years         2 years        1 months
  Infarction area                                                    Anterior wall+side wall   Anteroseptal+ high lateral wall   Inferior wall+back wall+right ventricle   Anterior wall   Inferior wall+high lateral wall+ back wall   Inferior wall   Inferior wall   Inferior wall
  Hospital ending                                                          Discharged                    Discharged                               Death                     Discharged                       Death                       Discharged         Death        Discharged
  Follow-up                                                                 No events                     No events                                ND                        No events                         ND                           Death            ND           No events

MN: membranous nephropathy; NA: not available; ND: no data.

Three people had coronary angiography and stent implantation. Two patients were treated with percutaneous transluminal coronary angioplasty (PTCA) only and two with thrombus spiration or thrombolysis. The incidence of cardiogenic shock was 3/8 (37.5%). The rate of no reflow or slow blood flow 3/8 (37.5%). In most patients, thrombosis is seen in coronary angiography, rather than in coronary atherosclerosis. Some people only do PTCA or thrombus and take the medicine in the coronary artery. The lesion of the blood vessel is dominated by the left anterior descending (LAD) and the right coronary artery (RCA). Most patients are found with either no reflow or slow blood flow ([Table 2](#jgc-14-07-481-t02){ref-type="table"}).

###### Angiography characteristics.

  Patients                         1             2             3       4          5           6     7                  8
  ------------------------------ ------ -------------------- ------ ------- -------------- ------- ---- -------------------------------
  Culprit vessel                  LAD           LAD           RCA     LAD         ND         RCA    ND                RCA
  Multi-vessel lesions            Yes            No           Yes     Yes         ND         Yes    ND                No
  Severe calcification             No            No           Yes     No          ND         No     ND                No
  Diffuse lesion                  Yes            No           Yes     Yes         ND         Yes    ND                No
  Treatment                       PTCA   Thrombus spiration   PTCA   Stent   Thrombolysis   stent   ND   Stent+thrombus Spiration+PTCA
  Number of stents                 0             0             0       2          0           3     ND                 1
  Length of stents                 ND            ND            ND    52 mm        ND        63 mm   ND               23 mm
  Thrombus spiration               No           Yes            No     No          ND         No     ND                Yes
  Cardiac shock                    No            No           Yes     Yes        Yes         No     ND                No
  No reflow or slow blood flow     No           Yes           Yes     No          ND         No     ND                Yes
  Intravascular medicine           No           Yes            No     No          ND         No     ND                Yes

LAD: left anterior descending; ND: no data; PTCA: percutaneous transluminal coronary angioplasty; RCA: right coronary artery.

The first report on coronary heart disease complicating NS was published 1969 by Berlyne and Mallick, who described the occurrence of AMI in four patients with NS due to glomemlonephritis. Now the combination of these diseases is still rare. Previous reports of such diseases are mostly case reports, and are mostly about young people.

We presented a case series of AMI secondary to NS mostly due to MN. In our cases, the age distribution is between 29 and 72 years old, It\'s interesting that the AMI occurs in patients of NS at all ages, not only young people. We also summarized the treatment of these patients. Most of the patients were treated with percutaneous coronary intervention and recovered well.

Most patients with coronary angiography can see a thrombosis, which can be identified as an acute coronary thrombosis, rather than an atheromatous plaque. In the treatment, some patients had a PTCA and did not implant stent, and the blood clots were taken from the blood clot. Coronary thrombosis can be seen in hypercoagulable states such as in the antiphospholipid syndrome, NS, and factor XII and protein S deficiencies, etc.[@b7]--[@b10] The possible pathogenesis of AMI in NS has been discussed in the former study.[@b11] The underlying mechanisms of the "thrombophilia" of the NS are multiple but seem related with an imbalance of prothrombotic factors. Firstly, factors associating with coagulation are enhanced. The proteinuria associated with NS leads to the loss of low molecular weight protein, such as factors IX, XI, and XII, as the liver tries to compensate for the hypoalbuminaemic state, there is an increased synthesis of factors II, VII, VIII, X, XIII, and fibrinogen.[@b12]--[@b14] Thrombocytosis and increased platelet aggregation and adhesiveness also contribute to the hypercoagulable state. Platelet hyperaggregability correlates with serum cholesterol concentrations. Secondly, factors associating with anticoagulation are weakened. Antithrombin III, a coagulation inhibitor significant reductions can be observed especially when the serum albumin concentration is below 20 g/L.

However, protein C and protein S are coagulation inhibitors whose decline has not been clearly implicated in arterial thrombosis in the NS. Thirdly, the imbalance of fibrinolytic system, with decreased concentrations of plasminogen and raised levels of plasminogen activator, contributes to the "thrombophilia".[@b15] There is evidence of decreased fibrinolytic activity with hypertriglyceridemia, which often occurs in the NS.[@b16] And the extent of alterations in imbalance of prothrombotic factors correlate with the degree of hypoalbuminaemia. A serum albumin of less than 25 g/L is a significant risk factor for combined arterial and venous thrombosis in the NS.[@b17] Other factors that contribute to the hypercoagulable state are a thrombocytosis and increased platelet aggregation and adhesiveness. Platelet hyperaggregability correlates with serum cholesterol concentrations.[@b18],[@b19] Many of these abnormalities were evident in our patient and may have caused coronary thrombosis without atherosclerotic plaque rupture.

Most of our patients are MN, which is a glomerular disease characterized by NS and typical changes on renal biopsy. Most patients present with a NS (80%). In the past, MN was considered as a presentation of chronic serum sickness. With research evolvement, MN like other glomerular diseases is now thought to be an autoimmune disease.[@b20] Oral hormone therapy is considered beneficial in the medium risk group (normal plasma creatinine, proteinuria between 4 and 8 g on a maximal conservative treatment).

In conclusion, the cases report indicates that AMI is probably due to arterial thrombosis that can be attributed to a hypercoagulable state resulting from the NS, which may be an independent risk factor of AMI. Although rare, AMI should be considered even without traditional risk factors. A detailed clinical history may help to identify the aetiology, and guide subsequent management, but diagnostic coronary angiography is essential. Aspirin is recommended in most cases. Anticoagulation should be considered in the NS if serum albumin is less than 20 g/L.[@b12] Careful risk factor modification and treatment of the underlying cause should reduce the incidence of recurrent cardiac events. In summary, NS is a rare cause of AMI. However, special attention should be paid to the high coagulation state. And anticoagulation should be considered as a prophylactic therapy.
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